Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Ivermectin: Ivermectin 12mg OD at night
Route of administration- Oral
Duration of therapy - 2 days with standard of care as per hospital guidelines
Intervention2: Ivermectin: Ivermect
Sponsors
R D Gardi Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults (age >=18 years to <=75 years) 2. Laboratory-confirmed SARS-CoV-2 infection and, in the view of the responsible doctor, no contra-indication to any of the study treatments 3. Hospitalized at R D Gardi Medical College, Ujjain Madhya Pradesh
Exclusion criteria
Exclusion criteria: 1. Anticipated transfer to another hospital, within 72 hours, which is not a study site 2. Known allergy to study medication or its components (non-medicinal ingredients) 3. Known HIV infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of Ivermectin on eradication of virus. Test for virus at 1, 3 and 5 days from beginning of trial drug started for the patient in the hospital Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Overall safety of the study drug 2. Duration of hospitalization 3. Improvement in the abnormal laboratory valuesTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Ashish Pathak
R D Gardi Medical College
Outcome results
None listed